4 | hematocrit | SS/JrHsdMcwi | male | 46.275 | % | naive control condition (for 14 days) | 58856 | naive control condition (for 14 days) | |

7 | hematocrit | SS-Chr 16BN/Mcwi | female | 45.6429 | % | naive control condition (for 14 days) | 58857 | naive control condition (for 14 days) | |

6 | hematocrit | SS-Chr 16BN/Mcwi | male | 46.7667 | % | naive control condition (for 14 days) | 58858 | naive control condition (for 14 days) | |

12 | hematocrit | FHH-Chr 12BN/Mcwi | female | 51.075 | % | air oxygen content (12 %) (for 14 days) | 59242 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS.BN-(D12Arb13-D12Rat79)/Mcwi | male | 55.21 | % | air oxygen content (12 %) (for 14 days) | 59243 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 2BN/Mcwi | female | 52.7375 | % | air oxygen content (12 %) (for 14 days) | 59244 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 6BN/Mcwi | male | 57.24 | % | air oxygen content (12 %) (for 14 days) | 59245 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | FHH-Chr 6BN/Mcwi | female | 52.8889 | % | air oxygen content (12 %) (for 14 days) | 59246 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS.BN-(D12Arb13-D12Rat79)/Mcwi | female | 56.225 | % | air oxygen content (12 %) (for 14 days) | 59247 | air oxygen content (12 %) (for 14 days) | |

11 | hematocrit | FHH-Chr 12BN/Mcwi | male | 55.1455 | % | air oxygen content (12 %) (for 14 days) | 59248 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 2BN/Mcwi | male | 56.6 | % | air oxygen content (12 %) (for 14 days) | 59249 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | FHH-Chr 10BN/Mcwi | female | 51.4429 | % | air oxygen content (12 %) (for 14 days) | 59250 | air oxygen content (12 %) (for 14 days) | |

17 | hematocrit | SHR/NCrl | male | 60.5471 | % | air oxygen content (12 %) (for 14 days) | 59251 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 5BN/Mcwi | female | 54.2375 | % | air oxygen content (12 %) (for 14 days) | 59252 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr XBN/Mcwi | male | 53.225 | % | air oxygen content (12 %) (for 14 days) | 59253 | air oxygen content (12 %) (for 14 days) | |

14 | hematocrit | SHR/NCrl | female | 54.6 | % | air oxygen content (12 %) (for 14 days) | 59254 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | SS-Chr 5BN/Mcwi | male | 55.9143 | % | air oxygen content (12 %) (for 14 days) | 59255 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 10BN/Mcwi | male | 53.3125 | % | air oxygen content (12 %) (for 14 days) | 59256 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | FHH-Chr XBN/Mcwi | female | 51.9429 | % | air oxygen content (12 %) (for 14 days) | 59257 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 8BN/Mcwi | female | 52.84 | % | air oxygen content (12 %) (for 14 days) | 59258 | air oxygen content (12 %) (for 14 days) | |

27 | hematocrit | SS-Chr 20BN/Mcwi | female | 53.5 | % | air oxygen content (12 %) (for 14 days) | 59259 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr 15BN/Mcwi | male | 56.14 | % | air oxygen content (12 %) (for 14 days) | 59260 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 15BN/Mcwi | female | 56.8625 | % | air oxygen content (12 %) (for 14 days) | 59261 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 8BN/Mcwi | male | 53.77 | % | air oxygen content (12 %) (for 14 days) | 59262 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 20BN/Mcwi | male | 54.07 | % | air oxygen content (12 %) (for 14 days) | 59263 | air oxygen content (12 %) (for 14 days) | |

12 | hematocrit | SS-Chr 13BN/Mcwi | female | 55.9167 | % | air oxygen content (12 %) (for 14 days) | 59264 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 18BN/Mcwi | male | 52.82 | % | air oxygen content (12 %) (for 14 days) | 59265 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 20BN/Mcwi | female | 51.14 | % | air oxygen content (12 %) (for 14 days) | 59266 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 18BN/Mcwi | female | 49.08 | % | air oxygen content (12 %) (for 14 days) | 59267 | air oxygen content (12 %) (for 14 days) | |

37 | hematocrit | SS-Chr 20BN/Mcwi | male | 54.1622 | % | air oxygen content (12 %) (for 14 days) | 59268 | air oxygen content (12 %) (for 14 days) | |

11 | hematocrit | SS-Chr 13BN/Mcwi | male | 57.1636 | % | air oxygen content (12 %) (for 14 days) | 59269 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | FHH-Chr YBN/Mcwi | male | 57.1444 | % | air oxygen content (12 %) (for 14 days) | 59270 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | SS-Chr 18BN/Mcwi | male | 55.5444 | % | air oxygen content (12 %) (for 14 days) | 59271 | air oxygen content (12 %) (for 14 days) | |

13 | hematocrit | FHH-Chr 1BN/Mcwi | male | 56.8692 | % | air oxygen content (12 %) (for 14 days) | 59272 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 4BN/Mcwi | male | 51.775 | % | air oxygen content (12 %) (for 14 days) | 59273 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | SS-Chr 18BN/Mcwi | female | 56.2111 | % | air oxygen content (12 %) (for 14 days) | 59274 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | FHH-Chr 4BN/Mcwi | female | 48.3571 | % | air oxygen content (12 %) (for 14 days) | 59275 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS.BN-(D8Rat163-D8Rat81)/Mcwi | female | 58.75 | % | air oxygen content (12 %) (for 14 days) | 59276 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr 19BN/Mcwi | male | 56.92 | % | air oxygen content (12 %) (for 14 days) | 59277 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 12BN/Mcwi | male | 55.4375 | % | air oxygen content (12 %) (for 14 days) | 59278 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr 19BN/Mcwi | female | 53.48 | % | air oxygen content (12 %) (for 14 days) | 59279 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr 2BN/Mcwi | female | 57.17 | % | air oxygen content (12 %) (for 14 days) | 59280 | air oxygen content (12 %) (for 14 days) | |

11 | hematocrit | SS.BN-(D8Rat163-D8Rat81)/Mcwi | male | 59.5091 | % | air oxygen content (12 %) (for 14 days) | 59281 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | SS-Chr 12BN/Mcwi | female | 53.7857 | % | air oxygen content (12 %) (for 14 days) | 59282 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | FHH-Chr 1BN/Mcwi | female | 55.3 | % | air oxygen content (12 %) (for 14 days) | 59283 | air oxygen content (12 %) (for 14 days) | |

15 | hematocrit | SS-Chr 2BN/Mcwi | male | 58.6867 | % | air oxygen content (12 %) (for 14 days) | 59284 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 15BN/Mcwi | male | 54.425 | % | air oxygen content (12 %) (for 14 days) | 59285 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr 10BN/Mcwi | male | 57.21 | % | air oxygen content (12 %) (for 14 days) | 59286 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 5BN/Mcwi | female | 51 | % | air oxygen content (12 %) (for 14 days) | 59287 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 14BN/Mcwi | female | 51.7 | % | air oxygen content (12 %) (for 14 days) | 59288 | air oxygen content (12 %) (for 14 days) | |

17 | hematocrit | SS-Chr 14BN/Mcwi | female | 53.4647 | % | air oxygen content (12 %) (for 14 days) | 59289 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 6BN/Mcwi | female | 57.0375 | % | air oxygen content (12 %) (for 14 days) | 59290 | air oxygen content (12 %) (for 14 days) | |

17 | hematocrit | SS-Chr 9BN/Mcwi | male | 57.2118 | % | air oxygen content (12 %) (for 14 days) | 59291 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 5BN/Mcwi | male | 52.275 | % | air oxygen content (12 %) (for 14 days) | 59292 | air oxygen content (12 %) (for 14 days) | |

20 | hematocrit | SS-Chr 14BN/Mcwi | male | 52.825 | % | air oxygen content (12 %) (for 14 days) | 59293 | air oxygen content (12 %) (for 14 days) | |

15 | hematocrit | SS-Chr 9BN/Mcwi | female | 56.1667 | % | air oxygen content (12 %) (for 14 days) | 59294 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | SS-Chr 6BN/Mcwi | male | 61 | % | air oxygen content (12 %) (for 14 days) | 59295 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 15BN/Mcwi | female | 54.1375 | % | air oxygen content (12 %) (for 14 days) | 59296 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr 10BN/Mcwi | female | 55.58 | % | air oxygen content (12 %) (for 14 days) | 59297 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 14BN/Mcwi | male | 53.45 | % | air oxygen content (12 %) (for 14 days) | 59298 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 17BN/Mcwi | male | 51.725 | % | air oxygen content (12 %) (for 14 days) | 59299 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | FHH-Chr 16BN/Mcwi | female | 52.5778 | % | air oxygen content (12 %) (for 14 days) | 59300 | air oxygen content (12 %) (for 14 days) | |

17 | hematocrit | GH/OmrMcwi | female | 59.1294 | % | air oxygen content (12 %) (for 14 days) | 59301 | air oxygen content (12 %) (for 14 days) | |

11 | hematocrit | SS-Chr 7BN/Mcwi | male | 58.9182 | % | air oxygen content (12 %) (for 14 days) | 59302 | air oxygen content (12 %) (for 14 days) | |

6 | hematocrit | FHH-Chr 17BN/Mcwi | male | 54.3167 | % | air oxygen content (12 %) (for 14 days) | 59303 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 17BN/Mcwi | female | 50 | % | air oxygen content (12 %) (for 14 days) | 59304 | air oxygen content (12 %) (for 14 days) | |

6 | hematocrit | FHH-Chr 17BN/Mcwi | female | 49.5667 | % | air oxygen content (12 %) (for 14 days) | 59305 | air oxygen content (12 %) (for 14 days) | |

20 | hematocrit | GH/OmrMcwi | male | 58.505 | % | air oxygen content (12 %) (for 14 days) | 59306 | air oxygen content (12 %) (for 14 days) | |

12 | hematocrit | SS-Chr 7BN/Mcwi | female | 53.2333 | % | air oxygen content (12 %) (for 14 days) | 59307 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | FHH-Chr 16BN/Mcwi | male | 56.3444 | % | air oxygen content (12 %) (for 14 days) | 59308 | air oxygen content (12 %) (for 14 days) | |

16 | hematocrit | FHH/EurMcwi | female | 52.9938 | % | air oxygen content (12 %) (for 14 days) | 59309 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 19BN/Mcwi | male | 54.49 | % | air oxygen content (12 %) (for 14 days) | 59310 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 3BN/Mcwi | female | 49.125 | % | air oxygen content (12 %) (for 14 days) | 59311 | air oxygen content (12 %) (for 14 days) | |

15 | hematocrit | SS-Chr 16BN/Mcwi | female | 58.62 | % | air oxygen content (12 %) (for 14 days) | 59312 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | SS-Chr 3BN/Mcwi | male | 52.2571 | % | air oxygen content (12 %) (for 14 days) | 59313 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 19BN/Mcwi | female | 50.75 | % | air oxygen content (12 %) (for 14 days) | 59314 | air oxygen content (12 %) (for 14 days) | |

13 | hematocrit | SS-Chr 16BN/Mcwi | male | 59.8769 | % | air oxygen content (12 %) (for 14 days) | 59315 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 13BN/Mcwi | female | 49.64 | % | air oxygen content (12 %) (for 14 days) | 59316 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 13BN/Mcwi | male | 54.41 | % | air oxygen content (12 %) (for 14 days) | 59317 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | SS-Chr 3BN/Mcwi | female | 48.0714 | % | air oxygen content (12 %) (for 14 days) | 59318 | air oxygen content (12 %) (for 14 days) | |

17 | hematocrit | SS-Chr 11BN/Mcwi | female | 52.7529 | % | air oxygen content (12 %) (for 14 days) | 59319 | air oxygen content (12 %) (for 14 days) | |

46 | hematocrit | FHH/EurMcwi | male | 55.2935 | % | air oxygen content (12 %) (for 14 days) | 59320 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | FHH-Chr 3BN/Mcwi | male | 51.3625 | % | air oxygen content (12 %) (for 14 days) | 59321 | air oxygen content (12 %) (for 14 days) | |

15 | hematocrit | SS-Chr 11BN/Mcwi | male | 52.9 | % | air oxygen content (12 %) (for 14 days) | 59322 | air oxygen content (12 %) (for 14 days) | |

20 | hematocrit | SS-Chr YBN/Mcwi | male | 61.575 | % | air oxygen content (12 %) (for 14 days) | 59323 | air oxygen content (12 %) (for 14 days) | |

90 | hematocrit | SS/JrHsdMcwi | male | 57.9667 | % | air oxygen content (12 %) (for 14 days) | 59324 | air oxygen content (12 %) (for 14 days) | |

11 | hematocrit | SS-Chr 1BN/Mcwi | male | 56.1182 | % | air oxygen content (12 %) (for 14 days) | 59325 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr XBN/Mcwi | female | 55.54 | % | air oxygen content (12 %) (for 14 days) | 59326 | air oxygen content (12 %) (for 14 days) | |

12 | hematocrit | SS-Chr 1BN/Mcwi | female | 54.3833 | % | air oxygen content (12 %) (for 14 days) | 59327 | air oxygen content (12 %) (for 14 days) | |

20 | hematocrit | SS-Chr 4BN/Mcwi | male | 54.61 | % | air oxygen content (12 %) (for 14 days) | 59328 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS/JrHsdMcwi | female | 56.07 | % | air oxygen content (12 %) (for 14 days) | 59329 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | FHH-Chr 11BN/Mcwi | male | 55.8889 | % | air oxygen content (12 %) (for 14 days) | 59330 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 11BN/Mcwi | female | 51.41 | % | air oxygen content (12 %) (for 14 days) | 59331 | air oxygen content (12 %) (for 14 days) | |

18 | hematocrit | SS-Chr 4BN/Mcwi | female | 53.2611 | % | air oxygen content (12 %) (for 14 days) | 59332 | air oxygen content (12 %) (for 14 days) | |

6 | hematocrit | FHH-Chr 9BN/Mcwi | female | 49.0167 | % | air oxygen content (12 %) (for 14 days) | 59333 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 7BN/Mcwi | female | 52.25 | % | air oxygen content (12 %) (for 14 days) | 59334 | air oxygen content (12 %) (for 14 days) | |

20 | hematocrit | BN/NHsdMcwi | male | 55.485 | % | air oxygen content (12 %) (for 14 days) | 59335 | air oxygen content (12 %) (for 14 days) | |

17 | hematocrit | BN/NHsdMcwi | female | 54.0529 | % | air oxygen content (12 %) (for 14 days) | 59336 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS-Chr XBN/Mcwi | male | 54.99 | % | air oxygen content (12 %) (for 14 days) | 59337 | air oxygen content (12 %) (for 14 days) | |

6 | hematocrit | FHH-Chr 9BN/Mcwi | male | 53.2 | % | air oxygen content (12 %) (for 14 days) | 59338 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | FHH-Chr 7BN/Mcwi | male | 55.68 | % | air oxygen content (12 %) (for 14 days) | 59339 | air oxygen content (12 %) (for 14 days) | |

3 | hematocrit | SS/JrHsdMcwi | male | 55.3333 | % | air oxygen content (12 %) (for 14 days) | 58198 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | FHH/EurMcwi | female | 56 | % | air oxygen content (12 %) (for 14 days) | 58199 | air oxygen content (12 %) (for 14 days) | |

6 | hematocrit | SS-Chr 16BN/Mcwi | female | 54.9167 | % | air oxygen content (12 %) (for 14 days) | 58200 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | SS-Chr 16BN/Mcwi | male | 55.6571 | % | air oxygen content (12 %) (for 14 days) | 58201 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | FHH/EurMcwi | male | 58.5429 | % | air oxygen content (12 %) (for 14 days) | 58202 | air oxygen content (12 %) (for 14 days) | |

4 | hematocrit | SS/JrHsdMcwi | female | 55.675 | % | air oxygen content (12 %) (for 14 days) | 58203 | air oxygen content (12 %) (for 14 days) | |

13 | hematocrit | LE/BluGill | female | 45.8385 | % | naive control condition (for 14 days) | 59855 | naive control condition (for 14 days) | |

9 | hematocrit | LEW/Crl | male | 46.6778 | % | naive control condition (for 14 days) | 59856 | naive control condition (for 14 days) | |

11 | hematocrit | WKY/NCrl | female | 44.3182 | % | naive control condition (for 14 days) | 59857 | naive control condition (for 14 days) | |

16 | hematocrit | F344/DuCrl | female | 47.8125 | % | naive control condition (for 14 days) | 59858 | naive control condition (for 14 days) | |

13 | hematocrit | LE/BluGill | male | 45.8308 | % | naive control condition (for 14 days) | 59859 | naive control condition (for 14 days) | |

8 | hematocrit | Hsd:SD | male | 45.95 | % | naive control condition (for 14 days) | 60072 | naive control condition (for 14 days) | |

8 | hematocrit | Hsd:SD | female | 45.7 | % | naive control condition (for 14 days) | 60073 | naive control condition (for 14 days) | |

8 | hematocrit | SS-Chr 18BN/Mcwi | male | 46.475 | % | naive control condition (for 14 days) | 60116 | naive control condition (for 14 days) | |

20 | hematocrit | SS/JrHsdMcwi | male | 44.77 | % | naive control condition (for 14 days) | 60117 | naive control condition (for 14 days) | |

8 | hematocrit | FHH/EurMcwi | female | 47.425 | % | naive control condition (for 14 days) | 60118 | naive control condition (for 14 days) | |

6 | hematocrit | SS-Chr 16BN/Mcwi | female | 47.8333 | % | naive control condition (for 14 days) | 60119 | naive control condition (for 14 days) | |

10 | hematocrit | SHR/NCrl | female | 44.27 | % | naive control condition (for 14 days) | 60120 | naive control condition (for 14 days) | |

9 | hematocrit | SS-Chr 18BN/Mcwi | female | 45.8778 | % | naive control condition (for 14 days) | 60121 | naive control condition (for 14 days) | |

9 | hematocrit | GH/OmrMcwi | female | 47.9333 | % | naive control condition (for 14 days) | 60122 | naive control condition (for 14 days) | |

5 | hematocrit | SS-Chr 16BN/Mcwi | male | 48.8 | % | naive control condition (for 14 days) | 60123 | naive control condition (for 14 days) | |

7 | hematocrit | FHH/EurMcwi | male | 47.2286 | % | naive control condition (for 14 days) | 60124 | naive control condition (for 14 days) | |

19 | hematocrit | SS/JrHsdMcwi | female | 45.6211 | % | naive control condition (for 14 days) | 60125 | naive control condition (for 14 days) | |

11 | hematocrit | SHR/NCrl | male | 47.7636 | % | naive control condition (for 14 days) | 60126 | naive control condition (for 14 days) | |

9 | hematocrit | GH/OmrMcwi | male | 49.4889 | % | naive control condition (for 14 days) | 60127 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 15BN/Mcwi | male | 42.7 | % | naive control condition (for 14 days) | 57469 | naive control condition (for 14 days) | |

11 | hematocrit | FHH-Chr 12BN/Mcwi | female | 42.4273 | % | naive control condition (for 14 days) | 57470 | naive control condition (for 14 days) | |

15 | hematocrit | SS-Chr 10BN/Mcwi | male | 40.68 | % | naive control condition (for 14 days) | 57471 | naive control condition (for 14 days) | |

10 | hematocrit | SS.BN-(D12Arb13-D12Rat79)/Mcwi | male | 45.66 | % | naive control condition (for 14 days) | 57472 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 14BN/Mcwi | female | 39.7375 | % | naive control condition (for 14 days) | 57473 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 2BN/Mcwi | female | 39.5125 | % | naive control condition (for 14 days) | 57474 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 5BN/Mcwi | female | 40.5 | % | naive control condition (for 14 days) | 57475 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 14BN/Mcwi | female | 42.54 | % | naive control condition (for 14 days) | 57476 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 6BN/Mcwi | male | 42.98 | % | naive control condition (for 14 days) | 57477 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 6BN/Mcwi | female | 44.47 | % | naive control condition (for 14 days) | 57478 | naive control condition (for 14 days) | |

9 | hematocrit | SS-Chr 9BN/Mcwi | male | 45 | % | naive control condition (for 14 days) | 57479 | naive control condition (for 14 days) | |

10 | hematocrit | SS.BN-(D12Arb13-D12Rat79)/Mcwi | female | 43.99 | % | naive control condition (for 14 days) | 57480 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 6BN/Mcwi | female | 39.65 | % | naive control condition (for 14 days) | 57481 | naive control condition (for 14 days) | |

7 | hematocrit | FHH-Chr 5BN/Mcwi | male | 42.1429 | % | naive control condition (for 14 days) | 57482 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 14BN/Mcwi | male | 42.22 | % | naive control condition (for 14 days) | 57483 | naive control condition (for 14 days) | |

9 | hematocrit | SS-Chr 9BN/Mcwi | female | 46.4333 | % | naive control condition (for 14 days) | 57484 | naive control condition (for 14 days) | |

9 | hematocrit | SS-Chr 6BN/Mcwi | male | 44.4556 | % | naive control condition (for 14 days) | 57485 | naive control condition (for 14 days) | |

12 | hematocrit | FHH-Chr 12BN/Mcwi | male | 43.7333 | % | naive control condition (for 14 days) | 57486 | naive control condition (for 14 days) | |

13 | hematocrit | SS-Chr 10BN/Mcwi | female | 42.8231 | % | naive control condition (for 14 days) | 57487 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 15BN/Mcwi | female | 41.1625 | % | naive control condition (for 14 days) | 57488 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 14BN/Mcwi | male | 40.2 | % | naive control condition (for 14 days) | 57489 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 2BN/Mcwi | male | 42.4375 | % | naive control condition (for 14 days) | 57490 | naive control condition (for 14 days) | |

11 | hematocrit | SS-Chr 17BN/Mcwi | male | 40.6455 | % | naive control condition (for 14 days) | 57491 | naive control condition (for 14 days) | |

7 | hematocrit | FHH-Chr 10BN/Mcwi | female | 36.3571 | % | naive control condition (for 14 days) | 57492 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 16BN/Mcwi | female | 43.3 | % | naive control condition (for 14 days) | 57493 | naive control condition (for 14 days) | |

11 | hematocrit | SS-Chr 7BN/Mcwi | male | 45.1818 | % | naive control condition (for 14 days) | 57494 | naive control condition (for 14 days) | |

5 | hematocrit | GH/OmrMcwi | female | 48.26 | % | naive control condition (for 14 days) | 57495 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 17BN/Mcwi | male | 41.3 | % | naive control condition (for 14 days) | 57496 | naive control condition (for 14 days) | |

12 | hematocrit | SS-Chr 17BN/Mcwi | female | 42.3333 | % | naive control condition (for 14 days) | 57497 | naive control condition (for 14 days) | |

7 | hematocrit | SS-Chr 5BN/Mcwi | female | 40.7429 | % | naive control condition (for 14 days) | 57498 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 17BN/Mcwi | female | 39.7667 | % | naive control condition (for 14 days) | 57499 | naive control condition (for 14 days) | |

4 | hematocrit | GH/OmrMcwi | male | 48.725 | % | naive control condition (for 14 days) | 57500 | naive control condition (for 14 days) | |

11 | hematocrit | SS-Chr 7BN/Mcwi | female | 43.8364 | % | naive control condition (for 14 days) | 57501 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr XBN/Mcwi | male | 42.225 | % | naive control condition (for 14 days) | 57502 | naive control condition (for 14 days) | |

8 | hematocrit | SS-Chr 5BN/Mcwi | male | 40.575 | % | naive control condition (for 14 days) | 57503 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 10BN/Mcwi | male | 37.81 | % | naive control condition (for 14 days) | 57504 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr XBN/Mcwi | female | 38.15 | % | naive control condition (for 14 days) | 57505 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 16BN/Mcwi | male | 43.28 | % | naive control condition (for 14 days) | 57506 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 8BN/Mcwi | female | 40.77 | % | naive control condition (for 14 days) | 57507 | naive control condition (for 14 days) | |

21 | hematocrit | SS-Chr 20BN/Mcwi | female | 44.5714 | % | naive control condition (for 14 days) | 57508 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 19BN/Mcwi | male | 40.1875 | % | naive control condition (for 14 days) | 57509 | naive control condition (for 14 days) | |

14 | hematocrit | FHH/EurMcwi | female | 44.3714 | % | naive control condition (for 14 days) | 57510 | naive control condition (for 14 days) | |

7 | hematocrit | SS-Chr 16BN/Mcwi | female | 45.3429 | % | naive control condition (for 14 days) | 57511 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 3BN/Mcwi | female | 39.725 | % | naive control condition (for 14 days) | 57512 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 15BN/Mcwi | male | 43.74 | % | naive control condition (for 14 days) | 57513 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 3BN/Mcwi | male | 42.57 | % | naive control condition (for 14 days) | 57514 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 15BN/Mcwi | female | 44.16 | % | naive control condition (for 14 days) | 57515 | naive control condition (for 14 days) | |

7 | hematocrit | FHH-Chr 19BN/Mcwi | female | 40.1571 | % | naive control condition (for 14 days) | 57516 | naive control condition (for 14 days) | |

6 | hematocrit | SS-Chr 16BN/Mcwi | male | 44.0333 | % | naive control condition (for 14 days) | 57517 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 13BN/Mcwi | female | 40.5444 | % | naive control condition (for 14 days) | 57518 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 8BN/Mcwi | male | 43.8 | % | naive control condition (for 14 days) | 57519 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 3BN/Mcwi | female | 41.76 | % | naive control condition (for 14 days) | 57520 | naive control condition (for 14 days) | |

11 | hematocrit | SS-Chr 13BN/Mcwi | female | 43.4818 | % | naive control condition (for 14 days) | 57521 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 13BN/Mcwi | male | 42.92 | % | naive control condition (for 14 days) | 57522 | naive control condition (for 14 days) | |

13 | hematocrit | FHH-Chr 20BN/Mcwi | male | 41.3154 | % | naive control condition (for 14 days) | 57523 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 18BN/Mcwi | male | 43.6333 | % | naive control condition (for 14 days) | 57524 | naive control condition (for 14 days) | |

13 | hematocrit | FHH-Chr 20BN/Mcwi | female | 42.5846 | % | naive control condition (for 14 days) | 57525 | naive control condition (for 14 days) | |

22 | hematocrit | SS-Chr 20BN/Mcwi | male | 43.9955 | % | naive control condition (for 14 days) | 57526 | naive control condition (for 14 days) | |

10 | hematocrit | FHH-Chr 18BN/Mcwi | female | 43.53 | % | naive control condition (for 14 days) | 57527 | naive control condition (for 14 days) | |

12 | hematocrit | SS-Chr 11BN/Mcwi | female | 44.4 | % | naive control condition (for 14 days) | 57528 | naive control condition (for 14 days) | |

48 | hematocrit | FHH/EurMcwi | male | 43.4688 | % | naive control condition (for 14 days) | 57529 | naive control condition (for 14 days) | |

11 | hematocrit | SS-Chr 13BN/Mcwi | male | 43.2545 | % | naive control condition (for 14 days) | 57530 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 3BN/Mcwi | male | 40.9375 | % | naive control condition (for 14 days) | 57531 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr YBN/Mcwi | male | 38.5889 | % | naive control condition (for 14 days) | 57532 | naive control condition (for 14 days) | |

20 | hematocrit | SS-Chr YBN/Mcwi | male | 45.72 | % | naive control condition (for 14 days) | 57533 | naive control condition (for 14 days) | |

13 | hematocrit | SS-Chr 11BN/Mcwi | male | 43.8846 | % | naive control condition (for 14 days) | 57534 | naive control condition (for 14 days) | |

9 | hematocrit | SS-Chr 18BN/Mcwi | male | 46.1889 | % | naive control condition (for 14 days) | 57535 | naive control condition (for 14 days) | |

87 | hematocrit | SS/JrHsdMcwi | male | 44.5149 | % | naive control condition (for 14 days) | 57536 | naive control condition (for 14 days) | |

6 | hematocrit | SS-Chr 1BN/Mcwi | male | 42.7 | % | naive control condition (for 14 days) | 57537 | naive control condition (for 14 days) | |

8 | hematocrit | SS-Chr XBN/Mcwi | female | 44.25 | % | naive control condition (for 14 days) | 57538 | naive control condition (for 14 days) | |

12 | hematocrit | FHH-Chr 1BN/Mcwi | male | 46.9583 | % | naive control condition (for 14 days) | 57539 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 18BN/Mcwi | female | 47.4 | % | naive control condition (for 14 days) | 57540 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 4BN/Mcwi | male | 41.9222 | % | naive control condition (for 14 days) | 57541 | naive control condition (for 14 days) | |

7 | hematocrit | SS-Chr 1BN/Mcwi | female | 41.6429 | % | naive control condition (for 14 days) | 57542 | naive control condition (for 14 days) | |

12 | hematocrit | SS-Chr 4BN/Mcwi | male | 43.675 | % | naive control condition (for 14 days) | 57543 | naive control condition (for 14 days) | |

12 | hematocrit | SS/JrHsdMcwi | female | 46.1333 | % | naive control condition (for 14 days) | 57544 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 11BN/Mcwi | male | 44.55 | % | naive control condition (for 14 days) | 57545 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 4BN/Mcwi | female | 41.4111 | % | naive control condition (for 14 days) | 57546 | naive control condition (for 14 days) | |

11 | hematocrit | SS.BN-(D8Rat163-D8Rat81)/Mcwi | female | 47.6818 | % | naive control condition (for 14 days) | 57547 | naive control condition (for 14 days) | |

7 | hematocrit | SS-Chr 19BN/Mcwi | male | 42.0571 | % | naive control condition (for 14 days) | 57548 | naive control condition (for 14 days) | |

10 | hematocrit | SS-Chr 12BN/Mcwi | male | 40.1 | % | naive control condition (for 14 days) | 57549 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 11BN/Mcwi | female | 42.7 | % | naive control condition (for 14 days) | 57550 | naive control condition (for 14 days) | |

15 | hematocrit | SS-Chr 4BN/Mcwi | female | 43.8867 | % | naive control condition (for 14 days) | 57551 | naive control condition (for 14 days) | |

7 | hematocrit | SS-Chr 19BN/Mcwi | female | 42.4857 | % | naive control condition (for 14 days) | 57552 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 7BN/Mcwi | female | 41.4222 | % | naive control condition (for 14 days) | 57553 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 9BN/Mcwi | female | 37.6375 | % | naive control condition (for 14 days) | 57554 | naive control condition (for 14 days) | |

11 | hematocrit | SS-Chr 2BN/Mcwi | female | 45.8273 | % | naive control condition (for 14 days) | 57555 | naive control condition (for 14 days) | |

17 | hematocrit | SS.BN-(D8Rat163-D8Rat81)/Mcwi | male | 46.9294 | % | naive control condition (for 14 days) | 57556 | naive control condition (for 14 days) | |

8 | hematocrit | SS-Chr 12BN/Mcwi | female | 40.9375 | % | naive control condition (for 14 days) | 57557 | naive control condition (for 14 days) | |

18 | hematocrit | BN/NHsdMcwi | male | 45.1889 | % | naive control condition (for 14 days) | 57558 | naive control condition (for 14 days) | |

11 | hematocrit | BN/NHsdMcwi | female | 44.0364 | % | naive control condition (for 14 days) | 57559 | naive control condition (for 14 days) | |

8 | hematocrit | SS-Chr XBN/Mcwi | male | 44.55 | % | naive control condition (for 14 days) | 57560 | naive control condition (for 14 days) | |

9 | hematocrit | FHH-Chr 7BN/Mcwi | male | 41.9 | % | naive control condition (for 14 days) | 57561 | naive control condition (for 14 days) | |

8 | hematocrit | FHH-Chr 9BN/Mcwi | male | 37.8625 | % | naive control condition (for 14 days) | 57562 | naive control condition (for 14 days) | |

8 | hematocrit | SS-Chr 2BN/Mcwi | male | 45.4375 | % | naive control condition (for 14 days) | 57563 | naive control condition (for 14 days) | |

14 | hematocrit | FHH-Chr 1BN/Mcwi | female | 46.2857 | % | naive control condition (for 14 days) | 57564 | naive control condition (for 14 days) | |

8 | hematocrit | WKY/NCrl | male | 60.225 | % | air oxygen content (12 %) (for 14 days) | 58582 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | LEW/Crl | female | 61.875 | % | air oxygen content (12 %) (for 14 days) | 58583 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | Crl:CD(SD) | male | 56.5222 | % | air oxygen content (12 %) (for 14 days) | 58584 | air oxygen content (12 %) (for 14 days) | |

14 | hematocrit | F344/DuCrl | male | 59.3071 | % | air oxygen content (12 %) (for 14 days) | 58585 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | Crl:CD(SD) | female | 51.5556 | % | air oxygen content (12 %) (for 14 days) | 58586 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | LE/BluGill | female | 58.0667 | % | air oxygen content (12 %) (for 14 days) | 58587 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | LEW/Crl | male | 63.7333 | % | air oxygen content (12 %) (for 14 days) | 58588 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | WKY/NCrl | female | 59.4375 | % | air oxygen content (12 %) (for 14 days) | 58589 | air oxygen content (12 %) (for 14 days) | |

11 | hematocrit | F344/DuCrl | female | 59.9273 | % | air oxygen content (12 %) (for 14 days) | 58590 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | LE/BluGill | male | 59.49 | % | air oxygen content (12 %) (for 14 days) | 58591 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS-Chr 20BN/Mcwi | female | 55.7875 | % | air oxygen content (12 %) (for 14 days) | 57775 | air oxygen content (12 %) (for 14 days) | |

8 | hematocrit | SS/JrHsdMcwi | male | 57.1125 | % | air oxygen content (12 %) (for 14 days) | 57776 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | Hsd:SD | male | 57.8286 | % | air oxygen content (12 %) (for 14 days) | 57777 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | SS-Chr 20BN/Mcwi | male | 56.5111 | % | air oxygen content (12 %) (for 14 days) | 57778 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | Hsd:SD | female | 54.1143 | % | air oxygen content (12 %) (for 14 days) | 57779 | air oxygen content (12 %) (for 14 days) | |

10 | hematocrit | SS/JrHsdMcwi | female | 56.96 | % | air oxygen content (12 %) (for 14 days) | 57780 | air oxygen content (12 %) (for 14 days) | |

7 | hematocrit | Hsd:SD | male | 53.5714 | % | air oxygen content (12 %) (for 14 days) | 58816 | air oxygen content (12 %) (for 14 days) | |

5 | hematocrit | Hsd:SD | female | 57.32 | % | air oxygen content (12 %) (for 14 days) | 58817 | air oxygen content (12 %) (for 14 days) | |

9 | hematocrit | WKY/NCrl | male | 44.5222 | % | naive control condition (for 14 days) | 59850 | naive control condition (for 14 days) | |

10 | hematocrit | LEW/Crl | female | 48.31 | % | naive control condition (for 14 days) | 59851 | naive control condition (for 14 days) | |

9 | hematocrit | Crl:CD(SD) | male | 44.7 | % | naive control condition (for 14 days) | 59852 | naive control condition (for 14 days) | |

7 | hematocrit | F344/DuCrl | male | 47.4143 | % | naive control condition (for 14 days) | 59853 | naive control condition (for 14 days) | |

9 | hematocrit | Crl:CD(SD) | female | 45.3889 | % | naive control condition (for 14 days) | 59854 | naive control condition (for 14 days) | |

10 | hematocrit | SHR/NHsd | male | 43.3 | % | arterial catheter implantation (for 1 days) | 107242 | arterial catheter implantation (for 1 days) | |

9 | hematocrit | ACI/SegHsd | male | 35.1 | % | arterial catheter implantation (for 1 days) | 107231 | arterial catheter implantation (for 1 days) | |

11 | hematocrit | BN/HsdMcwiCrl | male | 37.1 | % | arterial catheter implantation (for 1 days) | 107233 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | COP/OlaHsd | male | 36.9 | % | arterial catheter implantation (for 1 days) | 107234 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | F344/NHsd | male | 42 | % | arterial catheter implantation (for 1 days) | 107235 | arterial catheter implantation (for 1 days) | |

9 | hematocrit | LEW/NHsd | male | 40 | % | arterial catheter implantation (for 1 days) | 107237 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | PVG/OlaHsd | male | 41.7 | % | arterial catheter implantation (for 1 days) | 107238 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | SR/Hsd | male | 42.5 | % | arterial catheter implantation (for 1 days) | 107239 | arterial catheter implantation (for 1 days) | |

8 | hematocrit | SS/HsdMcwiCrl | male | 39.3 | % | arterial catheter implantation (for 1 days) | 107240 | arterial catheter implantation (for 1 days) | |

9 | hematocrit | DA/OlaHsd | male | 39 | % | arterial catheter implantation (for 1 days) | 107241 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | BN/Crl | male | 41.8 | % | arterial catheter implantation (for 1 days) | 107243 | arterial catheter implantation (for 1 days) | |

11 | hematocrit | Crl:SD | male | 40.9 | % | arterial catheter implantation (for 1 days) | 107244 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | FHH/EurMcwiCrl | male | 39.4 | % | arterial catheter implantation (for 1 days) | 107245 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | MWF/Hsd | male | 37.7 | % | arterial catheter implantation (for 1 days) | 107246 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | BDIX/CrCrl | male | 43.2 | % | arterial catheter implantation (for 1 days) | 107247 | arterial catheter implantation (for 1 days) | |

10 | hematocrit | NBL/CrCrl | male | 44 | % | arterial catheter implantation (for 1 days) | 107248 | arterial catheter implantation (for 1 days) | |

9 | hematocrit | ACI/SegHsd | male | 30.6 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107249 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

11 | hematocrit | BN/HsdMcwiCrl | male | 28.3 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107250 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | COP/OlaHsd | male | 29.7 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107251 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | F344/NHsd | male | 33 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107252 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

9 | hematocrit | LEW/NHsd | male | 31.6 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107253 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | PVG/OlaHsd | male | 32.8 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107254 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | SR/Hsd | male | 30.2 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107255 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

8 | hematocrit | SS/HsdMcwiCrl | male | 28.2 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107256 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

9 | hematocrit | DA/OlaHsd | male | 28.4 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107257 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | SHR/NHsd | male | 33.6 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107258 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | BN/Crl | male | 30.9 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107259 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

11 | hematocrit | Crl:SD | male | 29.8 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107260 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | FHH/EurMcwiCrl | male | 31.1 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107261 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | MWF/Hsd | male | 26.7 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107262 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | BDIX/CrCrl | male | 31.4 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107263 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |

10 | hematocrit | NBL/CrCrl | male | 35.8 | % | arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours) | 107264 | arterial catheter implantation (for 1 days) | controlled hemorrhage (between 1 and 6 hours) |